Analyst ratings often influence the short-term price movement of stocks. A 'Buy' rating from a reputable analyst like Joseph Stringer from Needham, coupled with a maintained price target of $35, indicates a positive outlook for Avidity Biosciences. This could lead to increased investor confidence and a potential rise in the stock's price.